FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics — Informed

Committee MeetingHouse

FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics

Held

Thursday, February 3, 2022

Rayburn House Office Building 2123

Held by

House Energy and Commerce Subcommittee on Health

Watch / read on Congress.gov

FDA User Fee Reauthorization: Ensuring Safe and Effective Drugs and Biologics — Informed